NasdaqCM - Nasdaq Real Time Price USD

Creative Medical Technology Holdings, Inc. (CELZ)

1.9800
-0.1600
(-7.48%)
At close: May 12 at 4:00:00 PM EDT
2.0800
+0.10
+(5.05%)
Pre-Market: 8:29:49 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11
11
9
88.6000
87.7540
Cost of Revenue
4.4000
4.4000
3.6000
28.4910
47.9490
Gross Profit
6.6000
6.6000
5.4000
60.1090
39.8050
Operating Expense
5,750.4610
5,750.4610
5,625.5320
10,304.4810
3,165.7540
Operating Income
-5,743.8610
-5,743.8610
-5,620.1320
-10,244.3720
-3,125.9490
Net Non Operating Interest Income Expense
250.3800
250.3800
333.5580
100.3280
-4,278.4330
Other Income Expense
--
--
--
--
26,616.1500
Pretax Income
-5,493.4810
-5,493.4810
-5,286.5740
-10,144.0440
19,211.7680
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-5,493.4810
-5,493.4810
-5,286.5740
-10,144.0440
19,211.7680
Diluted NI Available to Com Stockholders
-5,493.4810
-5,493.4810
-5,286.5740
-10,144.0440
19,211.7680
Basic EPS
-3.71
--
-3.76
-9.28
184.25
Diluted EPS
-3.71
--
-3.76
-9.28
140.25
Basic Average Shares
1,480.4200
--
1,407.6320
1,093.2040
104.2020
Diluted Average Shares
1,480.4200
--
1,407.6320
1,093.2040
129.9440
Total Operating Income as Reported
-5,743.8610
-5,743.8610
-5,620.1320
-10,244.3720
-3,125.9490
Total Expenses
5,754.8610
5,754.8610
5,629.1320
10,332.9720
3,213.7030
Net Income from Continuing & Discontinued Operation
-5,493.4810
-5,493.4810
-5,286.5740
-10,144.0440
19,211.7680
Normalized Income
-5,493.4810
-5,493.4810
-5,286.5740
-10,144.0440
-7,404.3820
Interest Income
250.3800
250.3800
333.5580
100.3280
0
Interest Expense
2,402.7460
--
--
0
4,278.4330
Net Interest Income
250.3800
250.3800
333.5580
100.3280
-4,278.4330
EBIT
-5,743.8610
-5,743.8610
-5,620.1320
-10,244.3720
23,490.2010
EBITDA
-5,633.4090
-5,633.4090
-5,525.5480
-10,152.2880
23,582.2850
Reconciled Cost of Revenue
4.4000
4.4000
3.6000
28.4910
47.9490
Reconciled Depreciation
110.4520
110.4520
94.5840
92.0840
92.0840
Net Income from Continuing Operation Net Minority Interest
-5,493.4810
-5,493.4810
-5,286.5740
-10,144.0440
19,211.7680
Total Unusual Items Excluding Goodwill
0
--
--
0
26,616.1500
Total Unusual Items
0
--
--
0
26,616.1500
Normalized EBITDA
-5,633.4090
-5,633.4090
-5,525.5480
-10,152.2880
-3,033.8650
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/6/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KZR Kezar Life Sciences, Inc.
4.2300
+0.24%
 
TSOI Therapeutic Solutions International, Inc.
0.0001
0.00%
 
TCBPY TC Biopharm (Holdings) Plc
0.3400
+4.04%
 
VYNE VYNE Therapeutics Inc.
1.2500
-3.85%
 
IGXT IntelGenx Technologies Corp.
0.1700
+1.80%
 
PMCB PharmaCyte Biotech, Inc.
1.0571
-2.12%
 
ENSC Ensysce Biosciences, Inc.
2.1900
+0.92%
 
BRTX BioRestorative Therapies, Inc.
1.8450
+3.07%
 
RGBPP Regen BioPharma, Inc.
0.0521
0.00%
 
APVO Aptevo Therapeutics Inc.
0.3400
0.00%